Basically they've scrapped stage III to go in vitro as this is a much more telling study and better use of time and money...... However, the vagueness of their RNS updates needs addressing and I have emailed the company to convay my dismay, I suggest others do the same....
Warrents were issued Wednesday, since which time share price has been under pressure. 2.5m shares to move, shouldn't take long if not already sold. Next week should see a bounce
Well played Zebbo, profit is profit, however I think you may regret that come the end of September......Unless you find another company that goes up 30-50% in the next month....
That interview was from 9th July...so six weeks ago. Cathal has always guided that Covid Challenge Studies would be ready be year end. Given the recruitment push on HVIVO website and the incorporation of the Chimagents guys, the writing is on the wall here. Very exciting few months inbound. And then there's Imutex!
Has anyone had any comms with the company around the stage III trial and expected timeline? Was quite suprised they didn't outline this is the stage II results.......? Thanks
Demon - Acacia if still offloading will have minuscule amount left. My opinion was they offloaded 25 million to the market makers at 11.5p who have been drip feeding them into the market. But it'll soon dry up. We've absorb a 7% seller in Acacia and circa 20% dilution at 11p and we are at 13p and in the middle of a summer lull in the markets! Pretty good going I reckon! Plus I'm certain there's a lot of private investor not actually invested currently but are watching very closely. This will all soon change! Sit back and relax and let your money do the work!
Well well well.....what a brilliant update without having to reveal anything new. It's probably as positive a presentation as I've heard from any Company.
Revenues advancing on all fronts (including antibody testing) which is great to hear with around six revenue streams building out a larger framework for expansion. Challenge study models are advancing apace and I'd suggest there's been some major progress in this regard. Stated we'll be in the World news when these start. Not a matter of if but when! This is massive and will see years of Covid studies alongside RSV trials. Monitising one of the Worlds largest genomic data bases is almost ready for commercial roll out and Imutex will be disposed of before Christmas with a big focus on the valuation on NASDAQ of other similar but inferior outfits.
Or yes...and the Company is now profitable...
So, if we consider circa £80m revenue in 2021 which is a big possibility now, we can nail a company valution of £250m minimum to the mast going forward....and then we have a one off hand out from the Imutex sale.
Anyone selling or waiting on the sidelines for a lower entry price is crazy! If you're not careful you'll get left behind here. This is a low risk, high potential return investment in very uncertain markets and there isn't many of those around! Think about it.....
You all have me beat! Why sell shares in a gold and copper asset development company with gold at all time high and copper fundamentals long term about as strong as they get. These assets and others like them around the World will have to be developed otherwise industry will be unable to function as currently predicted.
I'm amazed how focused you've all become on AE. Given negotiations are advancing it would suggest that a deal is being worked. If it falls through another potential partner will step forward. AE's legal dispute is nothing to do with Asiamet yet some on here are making it that way. Personally hope that AE take the whole of KSK leaving Tony to focus on Beutong. Either way I fear investors are currently giving their shares away cheaply!
RE: It's all gone very quiet all of a sudden!23 Jul 2020 10:15
Interesting fact is that the sum of all the parts (NAV) just continues to increase daily... Worth looking at the valuation of less appealing NASDAQ listed companies similar to Imutex and their valuations!!! And that's just one tentacle of this business..... Opportunity for shareholders here is absolutely huge. Sit tight and let the flower blossom!